{"transactions":[{"id":1984654,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":116262,"kind":"person","name":"Agopyan Nadia","position":1,"cik":"0001784758","reported_name":"Agopyan Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-01T21:47:45.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":34154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in equal monthly installments over a four year period commencing on March 27, 2023 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":34154,"derivative":{"exercise_price":2.14,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":34154},"source":{"system":"sec-edgar","filing":"0001209191-23-014155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919123014155/doc4.xml","form_type":"4"}},{"id":2383021,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":116262,"kind":"person","name":"Agopyan Nadia","position":1,"cik":"0001784758","reported_name":"Agopyan Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Regulatory Affairs"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-22T22:01:21.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in equal monthly installments over a four year period commencing on March 17, 2022 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0.46,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-011745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919122011745/doc4.xml","form_type":"4"}},{"id":2864251,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":116262,"kind":"person","name":"Agopyan Nadia","position":1,"cik":"0001784758","reported_name":"Agopyan Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Regulatory Affairs"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-12T22:21:42.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in equal monthly installments over a four year period commencing on March 10, 2021 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.29,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-010256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919121010256/doc4.xml","form_type":"4"}},{"id":3214036,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":116262,"kind":"person","name":"Agopyan Nadia","position":1,"cik":"0001784758","reported_name":"Agopyan Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Regulatory Affairs"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-12T20:35:17.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":32700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":32700,"derivative":{"exercise_price":2.12,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":32700},"source":{"system":"sec-edgar","filing":"0001209191-20-018524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919120018524/doc4.xml","form_type":"4"}},{"id":3214035,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":116262,"kind":"person","name":"Agopyan Nadia","position":1,"cik":"0001784758","reported_name":"Agopyan Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Regulatory Affairs"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-12T20:35:17.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":7300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a bonus for 2019 performance granted under the Company's 2014 Omnibus Stock Ownership Plan. This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":7300,"derivative":{"exercise_price":2.12,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":7300},"source":{"system":"sec-edgar","filing":"0001209191-20-018524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919120018524/doc4.xml","form_type":"4"}},{"id":3434931,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":116262,"kind":"person","name":"Agopyan Nadia","position":1,"cik":"0001784758","reported_name":"Agopyan Nadia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Regulatory Affairs"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-08-19T21:09:05.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares underlying the Option shall vest on August 15, 2020, with the balance of the shares vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":4.8,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-19-046630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919119046630/doc4.xml","form_type":"4"}}]}